| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $117.6M | +34.8% |
| Gross Profit | $25.2M | +111.6% |
| R&D Expense | $4.2M | -27.6% |
| SG&A Expense | $46.5M | -6.0% |
| Operating Income | -$76.5M | +9.8% |
| Pre-tax Income | $36.6M | +149.7% |
| Income Tax | -$3.4M | -6.4% |
| Net Income | $41.1M | +155.5% |
| EPS (Basic) | $0.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $858.8M | +28.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $15.5M | +10.6% |
| Inventory | $33.1M | +8.7% |
| Current Assets | $936.1M | +0.3% |
| Total Assets | $1.17B | +2.3% |
| Current Liabilities | $49.7M | +20.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.8M | +144.0% |
| Capital Expenditures | $12.4M | +395.4% |
| Investing Cash Flow | $175.1M | +394.4% |
| Financing Cash Flow | -$1.2M | -19.5% |
| Free Cash Flow | $6.4M | +114.2% |
| +157.9% |
| EPS (Diluted) | $0.11 | +157.9% |
| Total Liabilities |
| $55.3M |
| +25.9% |
| Stockholders' Equity | $1.06B | -3.2% |